croneton: structure
ID Source | ID |
---|---|
PubMed CID | 34766 |
CHEMBL ID | 493480 |
CHEBI ID | 38483 |
SCHEMBL ID | 74938 |
MeSH ID | M0058261 |
Synonym |
---|
caswell no. 263aa |
carbamic acid, methyl-, alpha-(ethylthio)-o-tolyl ester |
einecs 249-981-9 |
arylmate |
ethiophencarbe [iso-french] |
2-ethylthiomethylphenyl n-methylcarbamate |
(2-ethylthiomethyl-phenyl)-n-methylcarbamate |
ethiofencarb [bsi:iso] |
croneton 500 |
ai3-29007 |
phenol, 2-((ethylthio)methyl)-, methylcarbamate |
2-ethyl-mercaptomethyl-phenyl-n-methylcarbamate |
alpha-(ethylthio)-o-tolyl methylcarbamate [iso:bsi] |
brn 2973224 |
chox 1901 |
bay-hox-1901 |
kronetone |
hox 1901 |
epa pesticide chemical code 112101 |
carbamic acid, methyl-, 2-(ethylthiomethyl)phenyl ester |
hsdb 7140 |
alpha-(ethylthio)-o-tolyl methylcarbamate |
29973-13-5 |
2-((ethylthio)methyl)phenyl methylcarbamate |
croneton |
ethiofencarb |
CHEBI:38483 , |
2-[(ethylsulfanyl)methyl]phenyl methylcarbamate |
2-((ethylthio)methyl)phenol methylcarbamate |
alpha-ethylthio-o-tolyl methylcarbamate |
NCGC00163882-01 |
bdbm50253090 |
[2-(ethylsulfanylmethyl)phenyl] n-methylcarbamate |
CHEMBL493480 , |
inchi=1/c11h15no2s/c1-3-15-8-9-6-4-5-7-10(9)14-11(13)12-2/h4-7h,3,8h2,1-2h3,(h,12,13) |
heznviyqeuhlni-uhfffaoysa- |
C18649 |
tox21_301356 |
NCGC00255441-01 |
dtxsid3037545 , |
cas-29973-13-5 |
dtxcid1017545 |
fy0yb813xv , |
ethiophencarbe |
unii-fy0yb813xv |
carbamic acid, methyl-,2-(ethylthiomethyl)phenyl ester |
AKOS015888329 |
phenol, 2-((ethylthio)methyl)-, 1-(n-methylcarbamate |
.alpha.-(ethylthio)-o-tolyl methylcarbamate |
croneton-500 |
ethiofencarb [hsdb] |
bay-hox 1901 |
carbamic acid, methyl-, .alpha.-(ethylthio)-o-tolyl ester |
chox-1901 |
ethiofencarb [iso] |
2-((ethylthio)methyl)phenyl n-methylcarbamate |
hox-1901 |
o-cresol, .alpha.-(ethylthio)-, methylcarbamate |
.alpha.-ethylthio-o-tolyl methylcarbamate |
SCHEMBL74938 |
phenol, 2-[(ethylthio)methyl]-, methylcarbamate |
2-[(ethylsulfanyl)methyl]phenyl n-methylcarbamate |
ethiofencarb, pestanal(r), analytical standard |
mfcd00055463 |
2-[(ethylthio)methyl]phenyl n-methylcarbamate |
ethiofencarb 100 microg/ml in cyclohexane |
2-(ethylthiomethyl)phenyl methylcarbamate, 9ci |
phenol, 2-((ethylthio)methyl)-, methylcarbamate (9ci) |
n-methyl-o-(2-ethylthiomethyl) phenylcarbamate |
J-017713 |
alpha-ethylthio-o-tolylmethyl carbamate |
2-(ethylthiomethyl)phenyl methylcarbamate |
Q3591963 |
Role | Description |
---|---|
carbamate insecticide | Derivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief. |
EC 3.1.1.7 (acetylcholinesterase) inhibitor | An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid. |
agrochemical | An agrochemical is a substance that is used in agriculture or horticulture. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
carbamate ester | Any ester of carbamic acid or its N-substituted derivatives. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
acetylcholinesterase | Homo sapiens (human) | Potency | 17.4923 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395; AID1347397; AID1347398 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 15.3111 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 0.1949 | 0.0002 | 14.3764 | 60.0339 | AID720691 |
pregnane X nuclear receptor | Homo sapiens (human) | Potency | 70.7946 | 0.0054 | 28.0263 | 1,258.9301 | AID720659 |
nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 34.3762 | 0.0006 | 27.2152 | 1,122.0200 | AID651741 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | IC50 (µMol) | 0.3700 | 0.3700 | 1.2700 | 3.2500 | AID390722 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
lipid droplet | Hormone-sensitive lipase | Rattus norvegicus (Norway rat) |
cytosol | Hormone-sensitive lipase | Rattus norvegicus (Norway rat) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID390724 | Inhibition of HSL in Wistar rat isolated fat cells at 10 uM by spectrophotometric assay | 2008 | Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20 | Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. |
AID390722 | Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay | 2008 | Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20 | Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.47) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (8.33%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |